Measuring opioid withdrawal symptoms
Part of Mental health clinical trials.
This study is developing a questionnaire to better measure opioid withdrawal symptoms. By participating, you'll help create a tool that may improve how withdrawal is assessed in future care and research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had opioid use disorder in the past year, either because you're currently in treatment for it or a saliva test showed you used opioids.
- You can speak and understand English comfortably.
- You've had opioid withdrawal symptoms at least once in the past 30 days.
- You are not pregnant or breastfeeding.
- You don't have a history of psychosis or mania, and you haven't had suicidal behavior in the past month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study looks at what opioid withdrawal looks like in the body and whether they can measure it in a meaningful way. You may join if you have an opioid use disorder, can show physical dependence, and are interested in tapering (gradually reducing) opioids under study care.
This trial tests if a ketone supplement can help reduce cravings during opioid withdrawal treatment. Participants take the supplement daily and are monitored for changes in craving and withdrawal symptoms.
This study tests whether the medication suvorexant can reduce drug cravings in people with opioid use disorder. You will take either suvorexant or a placebo and have your cravings measured in a safe setting.
This Phase 2 study tests whether buspirone can help reduce symptoms during opioid detox (withdrawal). You may be able to take part if you have opioid withdrawal and are planning medically supervised detox.
This study uses wearable sensors to track physical signs of opioid withdrawal and cravings over 14 days. It aims to better understand these symptoms in people currently taking or planning to start medication for opioid use disorder.
This trial tests a physical device (ADTPM 1) to help manage withdrawal symptoms in people who are dependent on opioids. The goal is to see if the device can safely reduce withdrawal discomfort.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.